These results confirm that the AR-V7 splice variant cooperates with ELK1 as a transcriptional co-activator in the same manner as AR(A/B) and that ELK1 is also necessary for AR-V7-dependent growth of prostate cancer cells. The gene discussed is AR; the disease is prostate carcinoma.